Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $76.35 USD
Change Today +1.32 / 1.76%
Volume 377.1K
CRL On Other Exchanges
Symbol
Exchange
Berlin
As of 8:04 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

charles river laboratories (CRL) Key Developments

Charles River Laboratories Seeks Acquisitions

Charles River Laboratories International, Inc. (NYSE:CRL) announced that the company is very interested in continuing to grow, both organically and through mergers and acquisitions.

Celsis International Ltd., Charles River Laboratories International, Inc. - M&A Call

To discuss the company entered into a definitive agreement to acquire Celsis International Ltd

Charles River Laboratories International Seeks Acquisitions

Charles River Laboratories International, Inc. (NYSE:CRL) is seeking acquisitions. Jim Foster, Charles River's Chairman, President & Chief Executive Officer, said "We are going to look at acquisition opportunities in our highest growth, highest margin businesses that have the best long term potential, of which EMD is number one. So this has been consistently our best business, and by best, I mean consistently highest growing and very profitable."

Charles River Laboratories International, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 10:00 AM

Charles River Laboratories International, Inc. Presents at Jefferies 2015 Global Healthcare Conference, Jun-02-2015 10:00 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States.

Charles River Laboratories International, Inc. Expands Revolving Credit Facility

Charles River Laboratories International, Inc. has expand the revolving credit facility to provide additional capacity for general corporate purposes, including acquisitions. The new facility includes a $400 million U.S. term loan and a revolver of up to $900 million, a portion of which can be drawn in foreign currencies. The drawn amounts in the new facility were $361.8 million on the revolver, denominated in U.S. dollars, euros and British pounds and the full $400 million on the term loan. These amounts are similar to the balances on former credit facility at the end of the first quarter.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CRL:US $76.35 USD +1.32

CRL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bioanalytical Systems Inc $1.53 USD -0.07
Ergomed PLC 180.00 GBp +1.50
PAREXEL International Corp $68.40 USD +1.70
PRA Health Sciences Inc $41.74 USD +1.13
WuXi PharmaTech Cayman Inc $40.80 USD -0.17
View Industry Companies
 

Industry Analysis

CRL

Industry Average

Valuation CRL Industry Range
Price/Earnings 28.0x
Price/Sales 2.7x
Price/Book 5.4x
Price/Cash Flow 23.2x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHARLES RIVER LABORATORIES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.